Progressive Reduction of Tolvaptan Doses in the Treatment of Chronic SIADH

Endocrine Abstracts
doi 10.1530/endoabs.37.ep673
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Efficacy and Safety of Tolvaptan in Treatment of SIADH; Case-Series From 2 UK Hospitals

Endocrine Abstracts
2015English

Review of Tolvaptan in the Treatment of Hyponatremia

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2011English

Chronic Progressive Motor Polyneuropathy After Ganglioside Treatment.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1994English

Tolvaptan in the Treatment of Acute Hyponatremia Associated With Acute Kidney Injury

Case Reports in Nephrology
2013English

Progressive Lenses in the Treatment of Esotropia.

JAPANESE ORTHOPTIC JOURNAL
1990English

The Integration of Technology Into Treatment Programs to Aid in the Reduction of Chronic Pain

Journal of Pain Management & Medicine
2016English

Actual Therapeutic Indication of an Old Drug: Urea for Treatment of Severely Symptomatic and Mild Chronic Hyponatremia Related to SIADH

Journal of Clinical Medicine
2014English

Factors Related to the Beneficial Effects of Tolvaptan Treatment for Hepatic Ascites

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2016English

The Syndrome of Inappropriate Antidiuretic Syndrome (SIADH) in Association With Riluzole and SSRI Treatment in an ALS Patient

Medical Case reports and Reviews
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy